Sun Pharma Advanced Research Company Limited has informed the Exchange about Copy of Newspaper Publication
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharma Advanced Research Company (SPARC) has submitted to NSE and BSE copies of newspaper advertisements published on August 5, 2025, containing the extract of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26). The ads were published in Financial Express (English, all editions) and Financial Express (Gujarati, Ahmedabad edition), as required under Regulation 47 of the SEBI Listing Regulations. The same results extract has also been made available on the company's website at sparc.life. The filing is signed by Kajal Damania, Company Secretary and Compliance Officer.
This is a routine regulatory compliance filing and does not contain any new financial information — the Q1 FY26 results were already disclosed earlier. No material impact on the stock price is expected from this disclosure.